{"paper_id":"84dfeb95-5152-4bfb-b5ad-fdd4321ba67e","body_text":"Full text\nPDFSelected References\nThese references are in PubMed. This may not be the complete list of references from this article.\n- Barbieri R. L., Canick J. A., Makris A., Todd R. B., Davies I. J., Ryan K. J. Danazol inhibits steroidogenesis. Fertil Steril. 1977 Aug;28(8):809–813. [PubMed] [Google Scholar]\n- Dmowski W. P. Endocrine properties and clinical application of danazol. Fertil Steril. 1979 Mar;31(3):237–251. doi: 10.1016/s0015-0282(16)43869-0. [DOI] [PubMed] [Google Scholar]\n- Hirschowitz J. S., Soler N. G., Wortsman J. Sex steroid levels during treatment of endometriosis. Obstet Gynecol. 1979 Oct;54(4):448–450. [PubMed] [Google Scholar]\n- Rannevik G. Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis. Postgrad Med J. 1979;55 (Suppl 5):14–20. [PubMed] [Google Scholar]\n- Reddy V. V., Rose L. I. delta 4-3-Ketosteroid 5 alpha-oxidoreductase in human uterine leiomyoma. Am J Obstet Gynecol. 1979 Oct 1;135(3):415–418. doi: 10.1016/0002-9378(79)90716-6. [DOI] [PubMed] [Google Scholar]\n- Tsang B. K., Henderson K. M., Armstrong D. T. Effect of danazol on estradiol-17beta and progesterone secretion by porcine ovarian cells in vitro. Am J Obstet Gynecol. 1979 Feb 1;133(3):256–259. doi: 10.1016/0002-9378(79)90675-6. [DOI] [PubMed] [Google Scholar]","source_license":"CC0","license_restricted":false}